Hot Pursuit     05-Aug-21
Alembic Pharma receives final approval for OCD treatment drug
Alembic Pharmaceuticals on Thursday announced that it has received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Clomipramine Hydrochloride Capsules.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Anafranil Capsules of SpecGX LLC. Clomipramine Hydrochloride Capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

According to IQVIA, Clomipramine Hydrochloride Capsules USP have an estimated market size of $32 million for twelve months ending June 2021. Alembic has a cumulative total of 149 ANDA approvals from USFDA.

Shares of Alembic Pharma were trading 1.07% lower at Rs 778 on BSE.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world.

Previous News
  Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon
 ( Market Commentary - Stock Alert 30-Sep-24   08:34 )
  Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
 ( Results - Announcements 09-May-24   15:06 )
  Alembic Pharma's Panelav unit successfully completes USFDA inspection
 ( Corporate News - 26-Jul-24   13:36 )
  Alembic Pharmaceuticals to hold AGM
 ( Corporate News - 22-Jun-24   17:42 )
  Alembic Pharma’s Gujarat unit gets EIR from USFDA
 ( Hot Pursuit - 28-Sep-24   13:02 )
  Alembic receives USFDA approval for Bromfenac Ophthalmic Solution
 ( Corporate News - 09-Jul-24   15:10 )
  Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
 ( Results - Announcements 05-May-23   17:32 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 16-Jul-24   14:30 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 09-May-24   14:56 )
  Alembic Pharmaceuticals receives multiple product approvals from USFDA
 ( Corporate News - 03-Jul-23   09:11 )
  Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav
 ( Corporate News - 06-May-24   08:52 )
Other Stories
  Transformers and Rectifiers gains on bagging order worth Rs 565-cr
  03-Oct-24   11:16
  Volumes jump at Just Dial Ltd counter
  03-Oct-24   11:00
  Yes Bank's loan book rises to Rs 2.36 lakh crore in Q2 FY25; deposits up over 18% YoY
  03-Oct-24   10:46
  Dabur India slides on forecasting mid-single digit revenue dip in Q2 FY25
  03-Oct-24   10:46
  KRN Heat Exchanger makes stellar debut
  03-Oct-24   10:31
  Maruti Suzuki total sales rises to 1,84,727 units in Sep’24
  03-Oct-24   10:12
  Metal shares gain
  03-Oct-24   10:00
  Basic materials shares gain
  03-Oct-24   10:00
  Telecom shares rise
  03-Oct-24   10:00
  JSW Steel Ltd Spikes 1.87%
  03-Oct-24   09:30
Back Top